维生素E用于预防对比诱导的病:系统性审查和元分析
Ahmed Ali Awaji1, Basel H Bakhamees2, Nouf K Alalshaikh3
1Arthroplasty and Lower Extremity Reconstruction Surgery, King Salman Armed Forces Hospital, Tabuk, SAU.
Cureus
|July 29, 2024
概括
维生素E显著降低了对比诱导的脏病 (CIN) 的风险,与IV盐水水化相比降低了59%. 需要进一步的研究来确认其有效性,并与其他预防疗法进行比较.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 放射学 放射学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 对比诱导性病 (CIN) 是放射性手术后的一种严重并发症.
- 对CIN的预防策略对于减轻患者风险和改善结果至关重要.
研究的目的:
- 评估维生素E在预防CIN方面的疗效和安全性,与静脉注射 (IV) 盐水相比.
- 综合维生素E现有临床试验的证据,用于CIN预防.
主要方法:
- 在主要数据库 (MEDLINE/PubMed,Cochrane,Web of Science等) 进行了全面的文献搜索. 在2024年5月11日之前.
- 包括六项临床试验,分析了主要结果 (CIN发病率,透析,死亡) 和次要结果 (血清肌素,GFR).
- 数据使用标准化平均差异 (SMD) 和风险比率 (RR) 与95%置信区间 (CI) 进行聚合.
主要成果:
- 与IV补水相比,维生素E的使用表明CIN发生的风险降低了59% (合并RR:0.41;95%CI:0.25,0.65;P<0.001).
- 维生素E组中没有患者需要脏替代疗法.
- 在维生素E组中,由于急性冠状动脉综合征,发生了一例死亡.
结论:
- 维生素E显示出作为一种有效的预防药物对抗CIN的承诺.
- 目前的证据基于少数研究,样本规模有限,方法限制有限.
- 需要进一步进行高质量的临床试验,以证实维生素E对IV水分和其他药物如N-乙囊的有效性.
相关概念视频
Radiological Investigation I: X-ray and CT
219
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
219
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
157
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
157


